Galt Pharmaceuticals Franchise
Cost, fees, owner earnings, closure rate and litigation for a Galt Pharmaceuticals franchise — pulled from the franchisor's own public FDD (2026), not its sales material.
Disclosure honesty
Galt Pharmaceuticals discloses earnings (Item 19) — but the grade is how honestly. We graded it C.
What their own earnings claim actually says
24 operational franchisees, 53 territories in 2025. Top third averaged $980K-$2.06M sales per territory; bottom third $0-$23.6K. Unaudited data, no assurance of earnings.
What a Galt Pharmaceuticals franchise actually costs to run
| Fee | Disclosed | Where it comes from |
|---|---|---|
| Initial franchise fee | $100,000 | Item 5 — paid up front, before you open |
| Total initial investment | $122,350 – $348,700 | Item 7 — franchisor's own low/high estimate |
Monthly technology fee $499; extensive penalty/compliance fees including liquidated damages 20-100% of initial fee based on termination year.
Royalty and ad-fund percentages are charged on gross sales — an owner pays them whether or not the location is profitable.
Galt Pharmaceuticals system size and owner turnover
| Total outlets | 63 |
| Ceased operations | 20 |
| Terminated by franchisor | 0 |
| Transferred to new owners | 1 |
| Closure rate | 31.7% of outlets |
20 non-renewals in 2025 (29% of 69 outlets); 6 net outlet decline YoY.
From Item 20 of the FDD 2026. Terminations and ceased operations are the franchisor's own count of owners who stopped — the number the sales pitch leaves out.
Is Galt Pharmaceuticals worth it? — how it compares to 436 similar franchises
| Startup cost | from $122,350 | about average (median $138,750) |
| Disclosure honesty | Grade C | typical for the category |
| Closure rate | 31.7% of outlets | worse than 98% of peers |
| Disclosed lawsuits | 0 | fewer than most |
Benchmarked against every other franchises franchise we've graded from public FDDs — the context the franchisor's pitch never gives you.
Owner take-home for a Galt Pharmaceuticals
The franchisor's framing: 24 operational franchisees, 53 territories in 2025. Top third averaged $980K-$2.06M sales … We reconstruct what an owner actually keeps, from their own FDD.
- Reconstructed owner P&L — net take-home after royalty, ad fund, rent, labor & debt
- Break-even timeline + cash-on-cash ROI
- Full fee stack + required-purchase markups
- Decoded real failure / closure rate
- How it ranks vs comparable franchises
- Validation-call playbook — the exact questions to ask
See a full sample report → · 30-day guarantee
Galt Pharmaceuticals franchise — frequently asked
- How much does a Galt Pharmaceuticals franchise cost?
- The FDD lists a total initial investment of about $122,350–$348,700, including a $100,000 initial franchise fee.
- How much do Galt Pharmaceuticals franchise owners make?
- 24 operational franchisees, 53 territories in 2025. Top third averaged $980K-$2.06M sales per territory; bottom third $0-$23.6K. Unaudited data, no assurance of earnings. We grade this disclosure C for honesty.
- What are the Galt Pharmaceuticals franchise fees?
- Galt Pharmaceuticals' FDD discloses a $100,000 initial franchise fee. Monthly technology fee $499; extensive penalty/compliance fees including liquidated damages 20-100% of initial fee based on termination year.
- What is the Galt Pharmaceuticals franchise profit margin?
- Galt Pharmaceuticals does not publish a franchisee net-profit margin — almost no franchisor does. What Item 19 actually shows: 24 operational franchisees, 53 territories in 2025. Top third averaged $980K-$2.06M sales per territory; bottom third $0-$23.6K. Unaudited data, no assurance of earnings. Recurring fees alone take about a fixed cut of gross sales, before rent, labor, food or debt service. Margin has to be reconstructed from the disclosure, not read off it.
- What is the Galt Pharmaceuticals franchise failure rate?
- 20 non-renewals in 2025 (29% of 69 outlets); 6 net outlet decline YoY.
- How many Galt Pharmaceuticals locations are there?
- Galt Pharmaceuticals' FDD reports 63 total outlets, with 20 that ceased operations in the most recent reporting year and 1 transferred to new owners. Item 20 is where system health shows up before the marketing does.
- Does Galt Pharmaceuticals have complaints or lawsuits?
- Galt Pharmaceuticals discloses no material litigation in Item 3 of the filing we reviewed. That's a positive signal, though it covers only what the franchisor is required to report.
- Is a Galt Pharmaceuticals franchise worth it?
- It depends on the numbers, not the pitch. Galt Pharmaceuticals scores C on disclosure honesty. Get the real owner take-home before you sign.
Own a Galt Pharmaceuticals? Add your real numbers (anonymous)
We publish only aggregated benchmarks — never your name. Contribute and we'll show you how your numbers compare.
Compare Galt Pharmaceuticals to similar franchises
See all franchises ranked by disclosure honesty →
Source: WI DFI Franchise Registration (2026). FranchiseValidate is independent and not affiliated with Galt Pharmaceuticals or its franchisor. Figures are extracted from the franchisor's own public disclosure document; verify against the current FDD before any decision.